Indeed, PAR-2 inhibition prevented the IgG aPL-induced TF expression, suggesting that the TF/PAR-2 axis is directly involved in the pathogenesis of the thrombotic complications associated with APS [7,18,19]. This evidence concerns the gene TF and autoimmune polyendocrinopathy.